What counts as a hospital-acquired infection?

An infection that develops during a hospital stay and was neither present nor incubating at admission; in the ICU these are frequently associated with invasive devices such as ventilators, central venous catheters, and urinary catheters.

Why do hospital-acquired infections often require broader antibiotics than community infections?

Because patients who acquire infection during hospital care have usually been exposed to the hospital environment and to antimicrobials, the responsible organisms are more likely to be multidrug-resistant, which influences how empiric coverage is chosen.

Hospital-Acquired Infections (HAI) in ICU

Hospital-acquired infections, also called nosocomial or healthcare-associated infections, are infections that develop during a hospital stay and were not present or incubating at admission. In the intensive care unit they are most often linked to invasive devices and to the underlying severity of illness, and they form a major target of infection prevention and antimicrobial stewardship.

Troba un tema amb PaperMindAviatFind papers & topics

Tools & resources

Baixa les diapositives

Learn & explore

VídeoAviat

Definition

A hospital-acquired (nosocomial) infection is one that arises during the course of receiving healthcare and was neither present nor incubating at the time of admission; in critical care these are frequently device-associated, including ventilator-associated pneumonia, central line-associated bloodstream infection, and catheter-associated urinary tract infection.

Scope

This topic covers the principal ICU-associated infections, the device and host factors that drive them, and the prevention logic used to reduce them. It treats the main syndromes - ventilator-associated and hospital-acquired pneumonia, central line-associated bloodstream infection, and catheter-associated urinary tract infection - as a conceptual cluster. It is reference material describing the field and is not infection-control protocol or treatment guidance.

Core questions

Which infections in the ICU are attributable to care rather than to the admitting illness?
How do invasive devices change a patient's risk of infection?
Which hospital-acquired infections are preventable, and by what mechanisms?
How does the hospital-acquired versus community-acquired distinction shape empiric coverage?

Key concepts

Device-associated infection
Ventilator-associated pneumonia (VAP)
Central line-associated bloodstream infection (CLABSI)
Catheter-associated urinary tract infection (CAUTI)
Care bundles
Colonization versus infection
Multidrug-resistant nosocomial organisms

Mechanisms

Critically ill patients have impaired host defences and require invasive devices that bypass natural barriers: endotracheal tubes provide a conduit for lower-respiratory colonization and aspiration leading to ventilator-associated pneumonia (Kalil 2016), intravascular catheters create a portal for bloodstream invasion by skin and hub organisms (O'Grady 2011), and indwelling urinary catheters permit ascending bacteriuria (Hooton 2010). Prolonged exposure to the hospital environment and to broad-spectrum antimicrobials also selects for resistant nosocomial flora, so that hospital-acquired infections are more likely than community infections to involve resistant organisms.

Clinical relevance

Hospital-acquired infections lengthen ICU stay, add to morbidity and mortality, and shape empiric antimicrobial choices because of their association with resistant organisms. This entry explains how the syndromes are conceptualized and why prevention is emphasized; it is educational and does not provide diagnostic criteria, prevention protocols, or treatment regimens for use in care.

Epidemiology

Device-associated infections are among the most frequent hospital-acquired infections in intensive care, and surveillance definitions for VAP, CLABSI, and CAUTI underpin much of the prevention and benchmarking effort. Because ICU patients are heavily exposed to devices and antimicrobials, hospital-acquired infections in this setting disproportionately involve multidrug-resistant organisms, which informs how empiric therapy is selected (Kalil 2016).

History

Recognition that a large fraction of ICU infection is care-associated and partly preventable led to structured prevention guidance: the ATS/IDSA pneumonia guidelines (2005, updated 2016), the intravascular-catheter prevention guidelines (O'Grady 2011), and the catheter-associated UTI guidelines (Hooton 2010) together established the modern device-bundle approach to reducing hospital-acquired infection.

Debates

How should ventilator-associated pneumonia be defined and surveilled?: VAP diagnosis is hampered by non-specific signs and imperfect microbiology, and surveillance definitions have shifted toward objective ventilator-associated events; the tension between sensitive case-finding and specific, actionable definitions remains unresolved.

Seminal works

kalil-2016
ogrady-2011
hooton-2010

Frequently asked questions

What counts as a hospital-acquired infection?: An infection that develops during a hospital stay and was neither present nor incubating at admission; in the ICU these are frequently associated with invasive devices such as ventilators, central venous catheters, and urinary catheters.
Why do hospital-acquired infections often require broader antibiotics than community infections?: Because patients who acquire infection during hospital care have usually been exposed to the hospital environment and to antimicrobials, the responsible organisms are more likely to be multidrug-resistant, which influences how empiric coverage is chosen.